A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of Troriluzole in Generalized Anxiety Disorder

    Not Recruiting
Updated on 3 October 2022


The primary objective of the study is to evaluate the efficacy of troriluzole compared to placebo after 8-weeks of treatment in subjects with GAD, as measured by the Hamilton Anxiety Rating Scale (HAM-A) scale


Condition Generalized Anxiety Disorder (GAD)
Clinical Study IdentifierTX218077
Last Modified on3 October 2022

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note